Statement from Health Canada Regarding the Federal Court Decision of October 14, 2015
Statement
November 2, 2015 - Ottawa, ON - Health Canada
OTTAWA - On September 30, 2014, Health Canada published an Information Update and the Minister of Health issued a statement regarding a decision that had been made to restrict the importation of products from the following two Apotex facilities in India: Apotex Pharmachem India Pvt. Ltd. (APIPL) and Apotex Research Private Limited (ARPL).
On October 14, 2015, the Federal Court issued a judgment quashing the September 30, 2014 decision based on Health Canada and the Minister having proceeded unfairly and having acted for an improper purpose.
In accordance with the Court's judgment, Health Canada hereby retracts its Information Update and the Minister retracts her statement, both dated September 30, 2014.
Contacts
Media Relations
Health Canada
613-957-2983
Public Inquiries:
613-957-2991
1-866-225-0709
Search for related information by keyword